Press release
Global Gastric Cancer Market, Size, Share, Analysis Report & Forecast to 2026
The global market for gastric cancer is projected to have a considerable CAGR of around 6.8% during the forecast period. Gastric cancer is one of the most common forms of cancer across the globe. In gastric cancer, the malignant cells form in the lining of the stomach and develop slowly over many years. Bacterium Helicobacter pylori is a stomach infection that is one of the primary factors for the occurrence of gastric cancer. The high prevalence of gastrointestinal stromal tumours, carcinoid tumors, and lymphoma is one of the major factors for augmenting the treatment market of gastric cancer. An increase in the number of cancer treatment facilities across the globe is another major factor for the growth of the market. According to the American Cancer Society’s estimates for stomach cancer (also known as gastric cancer) in the US for 2021, there are about 26,560 new cases of stomach cancer (16,160 in men and 10,400 in women) are diagnosed, and about 11,180 people are died due to this type of cancer (6,740 men and 4,440 women) are registered. The growing elderly population, technological advancement and rising incidence and prevalence rate of gastric cancer are boosting the stomach cancer market across the globe.Get Free Sample Copy @ https://www.omrglobal.com/request-sample/gastric-cancer-market
The global gastric cancer market is segmented based on testing type, treatment type and end-users. Based on testing type, the market further segmented into chest x-ray, computed tomography (CT or CAT) scan, laparoscopy, magnetic resonance imaging (MRI) scan, positron emission tomography (PET) scan and Others. Similarly, on the basis of treatment type, the market is classified into chemotherapy, radiation therapy, surgery, targeted therapy, and immunotherapy. Among these, the targeted therapy segment is expected to show a significant growth rate during the forecast period. Delivery of advanced techniques including enzyme therapy and stem cell therapy is the primary factor for growth in the targeted therapy market. Targeted therapy tends to work in some cases where standard chemotherapy does not work. In such cases, trastuzumab, a targeted therapy drug, is given with chemotherapy. Based on end-user, the market is classified into hospitals & clinics, specialized cancer treatment centers and others.
A Full Report of Global Gastric Cancer Market is Available at: https://www.omrglobal.com/industry-reports/gastric-cancer-market
Geographically, the global Gastric Cancer market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Among these, the Asia-Pacific region is expected to grow at a considerable CAGR during the forecast period. Growing disposable income, awareness and healthcare spending are the major factor driving the growth of the gastric cancer market in the region. The rising prevalence of gastric cancer in various countries such as China, Japan, South Korea will create significant market growth for gastric cancer in the region.
Global Gastric Cancer Market– Segmentation
By Testing Type
Chest X-Ray
Computed Tomography (CT OR CAT) Scan
Laparoscopy
Magnetic Resonance Imaging (MRI) Scan
Positron Emission Tomography (PET) Scan
Others (Upper Gastrointestinal (GI) Series)
By Treatment Type
Chemotherapy
Radiation Therapy
Surgery
Targeted Therapy
Immunotherapy
By End-Users
Hospitals & Clinics
Specialized Cancer Treatment Centers
Others (Ambulatory Surgical Centers)
Global Gastric Cancer Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Abbott Laboratories
ASLAN Pharmaceuticals Pte Ltd.
AstraZeneca PLC
Athenex, Inc.
Bayer AG
Biogen Inc.
Bristol Myers Squibb Co.
Celltrion, Inc.
Danaher Corp.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
ImmunoGen, Inc.
Ipsen Pharma
Merck & Co., Inc.
Novartis International AG
Otsuka Holdings Co. Ltd.
Oncolytics Biotech, Inc.
Pacific Edge Ltd.
Pfizer Inc.
Thermo Fisher Scientific Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/gastric-cancer-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gastric Cancer Market, Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2411094 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
